Company intelligence / Profile preview

Jeil Pharmaceutical Co., Ltd.

Seoul, Seoul, South Koreajeilpharm.co.kr ↗
Ownership
Private
Employees
~4999
Development stage
Commercial
01

Overview

Jeil Pharmaceutical has a long history of commercialized generic and branded pharmaceuticals across multiple therapeutic areas. Its first in-house developed new drug Jaqbo (zastaprazan citrate) was launched in 2024 for GERD after successful Phase 3 trials. The company also has clinical-stage assets like JPI‑289 for stroke and licenses/markets innovative drugs such as Fetroja® for resistant bacterial infections in South Korea

Therapeutic areas
GastroenterologyCardiovascularPsychiatryOncologyInfectious Diseases
Modalities
Small moleculeschemical drugstransdermal patchesinjectables
Industry
Biotech
02

Drug pipeline

10 assets

olmesartan medoxomil

Approved

9 more assets in the full pipeline.

Request access →
03

Partnerships

Shionogi & Co., Ltd. – partnership/licensing for Fetroja® in South KoreaTakeda Korea – co-promotion agreementLundbeck Korea – co-promotion agreement

Beyond the preview

Go deeper on Jeil Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jeil Pharmaceutical Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call